Papers by Natasha Penner
3 results
- AAIC 2025 Abstract
Lecanemab Subcutaneous Formulation for Maintenance Dosing in Early Alzheimer’s Disease (AD)
Computational studyInterventions - AAIC 2025 Abstract
Clinical and Pharmacologic Profile of a Subcutaneous Lecanemab Formulation
Trial in peopleInterventions